Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Y Ma

Showing results (61-70 of 147) with videos related to

Pageof 15
Sort By:
Quantitative Imaging in Medicine and Surgery|September 3, 2021
A convolutional neural network combined with positional and textural attention for the fully automatic delineation of primary nasopharyngeal carcinoma on non-contrast-enhanced MRILun M Wong, Qi Yong H Ai, Darren M C Poon, et al.
Investigational New Drugs|August 27, 2013
Preclinical evaluation of the PI3K-mTOR dual inhibitor PF-04691502 as a novel therapeutic drug in nasopharyngeal carcinomaChi Hang Wong, Herbert H Loong, Connie W C Hui, et al.
AJNR. American Journal of Neuroradiology|June 26, 2025
Deep Invasion Volume of the Primary Nasopharyngeal Carcinoma Predicts Treatment OutcomeQi Yong H Ai, Ho Sang Leung, Frankie K F Mo, et al.
Journal of Proteome Research|December 2, 2006
Pharmacoproteomics study of cetuximab in nasopharyngeal carcinomaFion L Sung, Ronald T K Pang, Brigette B Y Ma, et al.
Head & Neck|September 3, 2025
Examining CD103<sup>+</sup> Tissue-Resident Memory T Cells in Nasopharyngeal CarcinomaAlesha A Thai, Richard J Young, Mathias Bressel, et al.
Oral Oncology|April 9, 2008
The prognostic significance of tumor vascular invasion and its association with plasma Epstein-Barr virus DNA, tumor volume and metabolic activity in locoregionally advanced nasopharyngeal carcinomaBrigette B Y Ma, Frankie K F Mo, Anthony T C Chan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 4, 2012
Prognostic significance of the total dose of cisplatin administered during concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinomaHerbert H Loong, Brigette B Y Ma, Sing-Fai Leung, et al.
Investigational New Drugs|August 12, 2023
Preclinical evaluation of the VEGF/Ang2 bispecific nanobody BI 836880 in nasopharyngeal carcinoma modelsRachel C T Lam, Connie W C Hui, C H Wong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2008
Plasma osteopontin, hypoxia, and response to radiotherapy in nasopharyngeal cancerEdwin P Hui, Fion L Sung, Brian K H Yu, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|March 13, 2025
Change in diffusion weighted imaging after induction chemotherapy outperforms RECIST guideline for long-term outcome prediction in advanced nasopharyngeal carcinomaQi Yong H Ai, Ho Sang Leung, Frankie K F Mo, et al.
Pageof 15

Showing results (61-70 of 147) with videos related to

Sort By:
Pageof 15
Quantitative Imaging in Medicine and Surgery|September 3, 2021
A convolutional neural network combined with positional and textural attention for the fully automatic delineation of primary nasopharyngeal carcinoma on non-contrast-enhanced MRILun M Wong, Qi Yong H Ai, Darren M C Poon, et al.
Investigational New Drugs|August 27, 2013
Preclinical evaluation of the PI3K-mTOR dual inhibitor PF-04691502 as a novel therapeutic drug in nasopharyngeal carcinomaChi Hang Wong, Herbert H Loong, Connie W C Hui, et al.
AJNR. American Journal of Neuroradiology|June 26, 2025
Deep Invasion Volume of the Primary Nasopharyngeal Carcinoma Predicts Treatment OutcomeQi Yong H Ai, Ho Sang Leung, Frankie K F Mo, et al.
Journal of Proteome Research|December 2, 2006
Pharmacoproteomics study of cetuximab in nasopharyngeal carcinomaFion L Sung, Ronald T K Pang, Brigette B Y Ma, et al.
Head & Neck|September 3, 2025
Examining CD103<sup>+</sup> Tissue-Resident Memory T Cells in Nasopharyngeal CarcinomaAlesha A Thai, Richard J Young, Mathias Bressel, et al.
Oral Oncology|April 9, 2008
The prognostic significance of tumor vascular invasion and its association with plasma Epstein-Barr virus DNA, tumor volume and metabolic activity in locoregionally advanced nasopharyngeal carcinomaBrigette B Y Ma, Frankie K F Mo, Anthony T C Chan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 4, 2012
Prognostic significance of the total dose of cisplatin administered during concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinomaHerbert H Loong, Brigette B Y Ma, Sing-Fai Leung, et al.
Investigational New Drugs|August 12, 2023
Preclinical evaluation of the VEGF/Ang2 bispecific nanobody BI 836880 in nasopharyngeal carcinoma modelsRachel C T Lam, Connie W C Hui, C H Wong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2008
Plasma osteopontin, hypoxia, and response to radiotherapy in nasopharyngeal cancerEdwin P Hui, Fion L Sung, Brian K H Yu, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|March 13, 2025
Change in diffusion weighted imaging after induction chemotherapy outperforms RECIST guideline for long-term outcome prediction in advanced nasopharyngeal carcinomaQi Yong H Ai, Ho Sang Leung, Frankie K F Mo, et al.
Pageof 15